Evolent to release Q3 2026 financial results on Nov. 5, 2026

WASHINGTON, Oct. 9, 2026 // -- Evolent Health, Inc. (NYSE: EVH), a company focused on achieving better health outcomes for people with complex conditions, today announced it will release its third quarter 2026 financial results on Thursday, November 5, 2026, before market open, with a conference call to follow at 8:30 a.m. ET. Shareholders and interested participants may listen to a live broadcast of the conference call found on Evolent's investor relations website, Analysts interested in asking questions during the live call should dial 855.940.9467, or 412.317.6034 for international callers, and reference the "Evolent call" 15 minutes prior to the call. An audio playback of the conference call will be available on Evolent's investor relations website for 90 days after the call. About Evolent Evolent specializes in better health outcomes for people with complex conditions through proven solutions that make health care simpler and more affordable. Evolent serves a national base of leading payers and providers and is consistently recognized as a top place to work in health care nationally. Learn more about how Evolent is changing the way health care is delivered by visiting Contacts: investorrelations@evolent.com View original content to download multimedia: SOURCE Evolent Health, Inc. (END) Dow Jones Newswires October 09, 2026 16:30 ET (20:30 GMT) The statements in this document shall not be considered as an objective or independent explanation of the matters. Please note that this document (a) has not been prepared in accordance with legal requirements designed to promote the independence of investment research, and (b) is not subject to any prohibition on dealing ahead of the dissemination or publication of investment research.